vs
RHYTHM PHARMACEUTICALS, INC.（RYTM）与Star Equity Holdings, Inc.（STRR）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是Star Equity Holdings, Inc.的1.1倍（$60.1M vs $56.8M），Star Equity Holdings, Inc.净利率更高（-3.0% vs -92.6%，领先89.5%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs 69.0%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 29.5%）
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
该公司信息存在混淆，Stars Equity Holdings, Inc.为一家投资控股企业，而描述提及的Artists Equity是由本·阿弗莱克和马特·达蒙两位演员兼制片人于2022年11月创立的美国制片公司。
RYTM vs STRR — 直观对比
营收规模更大
RYTM
是对方的1.1倍
$56.8M
营收增速更快
RYTM
高出14.8%
69.0%
净利率更高
STRR
高出89.5%
-92.6%
两年增速更快
RYTM
近两年复合增速
29.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $60.1M | $56.8M |
| 净利润 | $-55.6M | $-1.7M |
| 毛利率 | 88.1% | — |
| 营业利润率 | -87.1% | -0.2% |
| 净利率 | -92.6% | -3.0% |
| 营收同比 | 83.8% | 69.0% |
| 净利润同比 | — | -192.1% |
| 每股收益（稀释后） | $-0.83 | $-0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RYTMSTRR
| Q1 26 | $60.1M | — | ||
| Q4 25 | $57.3M | $56.8M | ||
| Q3 25 | $51.3M | $48.0M | ||
| Q2 25 | $48.5M | $35.5M | ||
| Q1 25 | $32.7M | $31.9M | ||
| Q4 24 | $41.8M | $33.6M | ||
| Q3 24 | $33.3M | $36.9M | ||
| Q2 24 | $29.1M | $35.7M |
净利润RYTMSTRR
| Q1 26 | $-55.6M | — | ||
| Q4 25 | $-47.5M | $-1.7M | ||
| Q3 25 | $-52.9M | $-1.8M | ||
| Q2 25 | $-46.6M | $-688.0K | ||
| Q1 25 | $-49.5M | $-1.8M | ||
| Q4 24 | $-43.3M | $-585.0K | ||
| Q3 24 | $-43.6M | $-846.0K | ||
| Q2 24 | $-32.3M | $-441.0K |
毛利率RYTMSTRR
| Q1 26 | 88.1% | — | ||
| Q4 25 | 91.6% | — | ||
| Q3 25 | 89.3% | 43.0% | ||
| Q2 25 | 88.6% | — | ||
| Q1 25 | 88.8% | — | ||
| Q4 24 | 90.9% | — | ||
| Q3 24 | 88.5% | 50.5% | ||
| Q2 24 | 89.9% | — |
营业利润率RYTMSTRR
| Q1 26 | -87.1% | — | ||
| Q4 25 | -82.2% | -0.2% | ||
| Q3 25 | -102.6% | -3.4% | ||
| Q2 25 | -93.4% | -0.6% | ||
| Q1 25 | -143.7% | -5.4% | ||
| Q4 24 | -98.6% | -0.4% | ||
| Q3 24 | -132.0% | -1.2% | ||
| Q2 24 | -139.2% | -0.5% |
净利率RYTMSTRR
| Q1 26 | -92.6% | — | ||
| Q4 25 | -83.0% | -3.0% | ||
| Q3 25 | -103.1% | -3.7% | ||
| Q2 25 | -96.1% | -1.9% | ||
| Q1 25 | -151.4% | -5.5% | ||
| Q4 24 | -103.6% | -1.7% | ||
| Q3 24 | -131.2% | -2.3% | ||
| Q2 24 | -110.9% | -1.2% |
每股收益（稀释后）RYTMSTRR
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-0.73 | $-0.49 | ||
| Q3 25 | $-0.82 | $-0.54 | ||
| Q2 25 | $-0.75 | $-0.23 | ||
| Q1 25 | $-0.81 | $-0.59 | ||
| Q4 24 | $-0.71 | $-0.21 | ||
| Q3 24 | $-0.73 | $-0.28 | ||
| Q2 24 | $-0.55 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $340.6M | $10.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $122.9M | $65.7M |
| 总资产 | $442.3M | $113.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RYTMSTRR
| Q1 26 | $340.6M | — | ||
| Q4 25 | $388.9M | $10.3M | ||
| Q3 25 | $416.1M | $15.4M | ||
| Q2 25 | $291.0M | $16.8M | ||
| Q1 25 | $314.5M | $16.6M | ||
| Q4 24 | $320.6M | $17.0M | ||
| Q3 24 | $298.4M | $15.8M | ||
| Q2 24 | $319.1M | $14.7M |
总债务RYTMSTRR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $6.5M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益RYTMSTRR
| Q1 26 | $122.9M | — | ||
| Q4 25 | $139.1M | $65.7M | ||
| Q3 25 | $148.8M | $67.8M | ||
| Q2 25 | $-11.9M | $40.1M | ||
| Q1 25 | $18.9M | $39.5M | ||
| Q4 24 | $21.7M | $40.4M | ||
| Q3 24 | $11.2M | $42.9M | ||
| Q2 24 | $39.3M | $42.6M |
总资产RYTMSTRR
| Q1 26 | $442.3M | — | ||
| Q4 25 | $480.2M | $113.2M | ||
| Q3 25 | $506.9M | $117.1M | ||
| Q2 25 | $372.7M | $55.6M | ||
| Q1 25 | $386.7M | $53.2M | ||
| Q4 24 | $392.3M | $52.6M | ||
| Q3 24 | $363.6M | $52.6M | ||
| Q2 24 | $381.8M | $52.6M |
负债/权益比RYTMSTRR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-7.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-9.0M |
| 自由现金流率自由现金流/营收 | — | -15.8% |
| 资本支出强度资本支出/营收 | — | 3.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.0M |
8季度趋势，按日历期对齐
经营现金流RYTMSTRR
| Q1 26 | — | — | ||
| Q4 25 | $-25.4M | $-7.3M | ||
| Q3 25 | $-26.6M | $-2.7M | ||
| Q2 25 | $-23.3M | $139.0K | ||
| Q1 25 | $-40.4M | $-802.0K | ||
| Q4 24 | $-18.8M | $-2.8M | ||
| Q3 24 | $-25.2M | $1.3M | ||
| Q2 24 | $-29.1M | $-4.3M |
自由现金流RYTMSTRR
| Q1 26 | — | — | ||
| Q4 25 | — | $-9.0M | ||
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $102.0K | ||
| Q1 25 | — | $-808.0K | ||
| Q4 24 | — | $-2.8M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $-4.3M |
自由现金流率RYTMSTRR
| Q1 26 | — | — | ||
| Q4 25 | — | -15.8% | ||
| Q3 25 | — | -7.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | -2.5% | ||
| Q4 24 | — | -8.3% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | -12.0% |
资本支出强度RYTMSTRR
| Q1 26 | — | — | ||
| Q4 25 | — | 3.0% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RYTM
暂无分部数据
STRR
| Revenue From Other Contracts With Customers | $27.6M | 49% |
| Other | $24.3M | 43% |
| Energy Services Segment | $4.9M | 9% |
